Cargando…

Hypermethylation of the IRAK3-Activated MAPK Signaling Pathway to Promote the Development of Glioma

OBJECTIVE: This study aimed to elucidate the molecular mechanism underlying the involvement of abnormal DNA methylation in the development of glioma and identify potential new targets for glioma therapy. METHODS: The GSE79122 chip achieved from the Gene Expression Omnibus (GEO) database containing 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xinghai, Ouyang, Yian, Wang, Bin, Lin, Jian, Bai, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425661/ https://www.ncbi.nlm.nih.gov/pubmed/32848462 http://dx.doi.org/10.2147/CMAR.S252772

Ejemplares similares

Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023)

IRAK signalling in cancer
por: Rhyasen, G W, et al.
Publicado: (2015)

Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas
por: Zhang, Zuping, et al.
Publicado: (2008)

Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling
por: Lin, Su-Chang, et al.
Publicado: (2010)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma
por: Li, Jing, et al.
Publicado: (2022)

Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer
por: Hu, Yu-Han, et al.
Publicado: (2017)

A Standardized Chemically Modified Curcuma longa Extract Modulates IRAK-MAPK Signaling in Inflammation and Potentiates Cytotoxicity
por: Rana, Minakshi, et al.
Publicado: (2016)

Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion
por: Wu, Rile, et al.
Publicado: (2019)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Hypermethylation of MAPK13 Promoter in Oesophageal Squamous Cell Carcinoma Is Associated with Loss of p38δ MAPK Expression
por: O′Callaghan, Carol, et al.
Publicado: (2015)

Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas
por: He, Jiehua, et al.
Publicado: (2020)

Regulation of innate immune signaling by IRAK proteins
por: Pereira, Milton, et al.
Publicado: (2023)

Irak : cinco años después /
por: Rosas, María Cristina
Publicado: (2008)

Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
por: Mellai, Marta, et al.
Publicado: (2013)

Panax notoginseng Saponins Alleviate Coronary Artery Disease Through Hypermethylation of the miR-194-MAPK Pathway
por: Duan, Lian, et al.
Publicado: (2022)

Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway
por: Chen, Wei, et al.
Publicado: (2020)

IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
por: Bennett, Joshua, et al.
Publicado: (2022)

IRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
por: Tan, Qiyuan, et al.
Publicado: (2014)

Outgrowing IRAK-4
por: Bashyam, Hema
Publicado: (2007)

B cell antigen receptor-induced activation of an IRAK4-dependent signaling pathway revealed by a MALT1-IRAK4 double knockout mouse model
por: Dufner, Almut, et al.
Publicado: (2011)

IRAK3-mediated suppression of pro-inflammatory MyD88/IRAK signaling affects disease severity in acute pancreatitis
por: Thiel, Franziska G., et al.
Publicado: (2023)

The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways
por: Pereira, Milton, et al.
Publicado: (2022)

High Specificity of Quantitative Methylation-Specific PCR Analysis for MGMT Promoter Hypermethylation Detection in Gliomas
por: Parrella, Paola, et al.
Publicado: (2009)

Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas
por: Gu, Yuan, et al.
Publicado: (2020)

Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression
por: Yu, Jiayun, et al.
Publicado: (2021)

IRAK-4 Inhibitors for Inflammation
por: Wang, Zhulun, et al.
Publicado: (2009)

Long, Noncoding RNA SRA Induces Apoptosis of β-Cells by Promoting the IRAK1/LDHA/Lactate Pathway
por: Huang, Yu-Nan, et al.
Publicado: (2021)

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014)

Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia
por: Giménez, Neus, et al.
Publicado: (2019)

The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists
por: Vollmer, Stefan, et al.
Publicado: (2017)

Runx1 promotes the development of glioma cells by regulating JAK-STAT signalling pathway
por: Zhang, Yong, et al.
Publicado: (2019)

The Alphaviral Capsid Protein Inhibits IRAK1-Dependent TLR Signaling
por: Landers, V. Douglas, et al.
Publicado: (2021)

Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells
por: Li, Jing, et al.
Publicado: (2023)

Inhibition of IRAK1 Is an Effective Therapy for Autoimmune Hypophysitis in Mice
por: Huang, Hsiao-Chen, et al.
Publicado: (2022)

Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression
por: Liu, Bingbing, et al.
Publicado: (2021)

Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
por: Wu, Wenyi, et al.
Publicado: (2016)

Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis
por: Kang, Chenglin, et al.
Publicado: (2023)

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas
por: Gömöri, Éva, et al.
Publicado: (2012)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r921dkn4m5rprtvpsso8t956l4